Uncertainties still attached to the Transurban’s WestConnex project: Analyst

Ahead of winning stakes in Sydney’s WestConnex toll road, return uncertainties continue to hover around the Transurban’s (ASX:TCL) traffic forecasts for WestConnex.

This year in August, Transurban and its partners acquired 51% stakes in the Sydney Motorway Corporation, beating the arch rival bidder IFM investors. Transurban chief executive Scott Charlton has spent two years to add $9.3 billion motorway to the company’s stable which has been already holding seven out of nine Sydney’s toll road. [optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

But as things got back to normal post Transurban’s biggest-ever deal, analysts caution investors on the worth of billion dollars spent on WestConnex takeover deal. Analysts points out that Transurban has missed to provide information on how many cars and trucks are expected to use the 33-Km long motorway.

CEO Charlton previously indicated that Transurban’s traffic forecasts for newly acquired WestConnex were higher than that outline by NSW government in 2015, based on potential for traffic coming on and off the motorway from proposed projects such as the Western Harbour Tunnel.

But analysts are of the view that Transurban’s traffic forecast needs to be almost 50% more than the NSW’s government to generate a return above the company’s weighted average cost of capital, which is believed to be about 7 percent.

WestConnex motorway which won’t be finished until 2023, will connect with Transurban’s existing M5 toll road in Sydney’s southwest and will have connections to new proposed toll roads such as the Western Harbour Tunnel and the Sydney Gateway. TCL share price slipped by 0.353% to $11.300 on 12 September 2018 (6:03 PM AEST).

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report